IMP
Process View
cellular response to estrogen stimulus
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "cellular response to estrogen stimulus"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.914 | Human | |
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.344 | ||
| EGFR | epidermal growth factor receptor | 0.300 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 0.163 | ||
| RXRA | retinoid X receptor, alpha | 0.135 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.116 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.100 | Human | |
| CBX1 | chromobox homolog 1 | 0.080 | ||
| SRF | serum response factor (c-fos serum response element-binding transcription factor) | 0.078 | ||
| MPDZ | multiple PDZ domain protein | 0.068 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.065 | ||
| SP1 | Sp1 transcription factor | 0.062 | ||
| CDK11B | cyclin-dependent kinase 11B | 0.059 | ||
| MED1 | mediator complex subunit 1 | 0.056 | ||
| TRADD | TNFRSF1A-associated via death domain | 0.050 | ||
| NCOA2 | nuclear receptor coactivator 2 | 0.040 | ||
| FAM46A | family with sequence similarity 46, member A | 0.039 | ||
| IL10RA | interleukin 10 receptor, alpha | 0.034 | ||
| MED25 | mediator complex subunit 25 | 0.032 | ||
| HDAC3 | histone deacetylase 3 | 0.029 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.027 | ||
| SENP3 | SUMO1/sentrin/SMT3 specific peptidase 3 | 0.026 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.025 | ||
| MYLK2 | myosin light chain kinase 2 | 0.025 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.024 | ||
| ZNHIT1 | zinc finger, HIT-type containing 1 | 0.024 | ||
| CSRP3 | cysteine and glycine-rich protein 3 (cardiac LIM protein) | 0.024 | ||
| MAGEA2 | melanoma antigen family A, 2 | 0.023 | ||
| AR | androgen receptor | 0.022 | ||
| PRDX4 | peroxiredoxin 4 | 0.021 | ||
| C16orf53 | chromosome 16 open reading frame 53 | 0.021 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.021 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.021 | ||
| CREBBP | CREB binding protein | 0.020 | ||
| GRIN2C | glutamate receptor, ionotropic, N-methyl D-aspartate 2C | 0.020 | ||
| CANX | calnexin | 0.019 | ||
| TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.019 | ||
| WWOX | WW domain containing oxidoreductase | 0.019 | ||
| SSR2 | signal sequence receptor, beta (translocon-associated protein beta) | 0.018 | ||
| PAFAH1B3 | platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa) | 0.018 | ||
| THBS1 | thrombospondin 1 | 0.018 | ||
| DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.017 | ||
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.017 | ||
| PIK3R2 | phosphoinositide-3-kinase, regulatory subunit 2 (beta) | 0.017 | ||
| TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.015 | ||
| RPA3 | replication protein A3, 14kDa | 0.015 | ||
| TRO | trophinin | 0.014 | ||
| ENG | endoglin | 0.014 | ||
| SMARCA4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 0.014 | ||
| LAS1L | LAS1-like (S. cerevisiae) | 0.013 | ||
| DUSP23 | dual specificity phosphatase 23 | 0.013 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.013 | ||
| UGT2B15 | UDP glucuronosyltransferase 2 family, polypeptide B15 | 0.013 | Human | |
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.013 | ||
| C5orf41 | chromosome 5 open reading frame 41 | 0.013 | ||
| EDEM1 | ER degradation enhancer, mannosidase alpha-like 1 | 0.012 | ||
| GADD45A | growth arrest and DNA-damage-inducible, alpha | 0.012 | ||
| SEC61B | Sec61 beta subunit | 0.012 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.012 | ||
| PPP5C | protein phosphatase 5, catalytic subunit | 0.012 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.012 | ||
| HMGN1 | high mobility group nucleosome binding domain 1 | 0.011 | ||
| GABRA3 | gamma-aminobutyric acid (GABA) A receptor, alpha 3 | 0.011 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.011 | ||
| BARD1 | BRCA1 associated RING domain 1 | 0.011 | ||
| DLG3 | discs, large homolog 3 (Drosophila) | 0.011 | ||
| APP | amyloid beta (A4) precursor protein | 0.011 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.011 | ||
| THBS2 | thrombospondin 2 | 0.011 | ||
| TNF | tumor necrosis factor | 0.010 | ||
| SERPINA1 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | 0.010 |